You appear to be using incognito/private browsing mode or an ad blocker, which may adversely affect your experience on the site. Please disable any ad blockers and view the site in non-private mode.
For in vitro diagnostic use. Others HSCRP IVD HSCRP PID00000869 Tina-quant Cardiac high sensitivity CRP III 09 188 231 190 9 188 231 190 09188231190 9188231190 09188231190 HSCRP, 500T, cobas c pack green Tina-quant Cardiac high sensitivity CRP III 07613336224359 Reagents, kits 500 tests cobas c 303/503/703 true 09 188 266 190 9 188 266 190 09188266190 9188266190 09188266190 HSCRP, 250T, cobas c Tina-quant Cardiac high sensitivity CRP III 07613336224342 Reagents, kits 250 tests cobas c 311/501/502 true 09 188 240 190 9 188 240 190 09188240190 9188240190 09188240190 HSCRP, 300T, cobas c701/702 Tina-quant Cardiac high sensitivity CRP III 07613336224335 Reagents, kits 300 tests cobas c 701/702 true 09188231500 HSCRP Tina-quant Cardiac high sensitivity CRP III en 2 FF00000007146F0E FF00000006A81F0E 09188231190 10299 cobas c 703 9493 cobas c 303 8481 cobas c 503 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useIn vitro test for the quantitative determination of C‑reactive protein (CRP) in human serum and plasma on cobas c systems. CRP measurements, performed with this assay, in human serum or plasma, are used as aid in diagnosis, monitoring, prognosis, and management of suspected inflammatory disorders and associated diseases, acute infections and tissue injury. Highly sensitive measurement of CRP may also be used as an aid in the assessment of the risk of future coronary heart disease. When used as an adjunct to other laboratory evaluation methods of acute coronary syndromes, it may also be an additional independent indicator of recurrent event prognosis in patients with stable coronary disease or acute coronary syndrome. en 09188266500 HSCRP Tina-quant Cardiac high sensitivity CRP III en 1 FF00000006A35F0E FF00000006A35E0E 09188266190 308 cobas c 311 2324 cobas c 502 309 cobas c 501 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useIn vitro test for the quantitative determination of C‑reactive protein (CRP) in human serum and plasma on cobas c systems. CRP measurements, performed with this assay, in human serum or plasma, are used as aid in diagnosis, monitoring, prognosis, and management of suspected inflammatory disorders and associated diseases, acute infections and tissue injury. Highly sensitive measurement of CRP may also be used as an aid in the assessment of the risk of future coronary heart disease. When used as an adjunct to other laboratory evaluation methods of acute coronary syndromes, it may also be an additional independent indicator of recurrent event prognosis in patients with stable coronary disease or acute coronary syndrome. en 09188240500 HSCRP Tina-quant Cardiac high sensitivity CRP III en 1 FF00000006A8220E FF00000006A8220E 09188240190 2492 cobas c 702 310 cobas c 701 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useIn vitro test for the quantitative determination of C‑reactive protein (CRP) in human serum and plasma on cobas c systems. CRP measurements, performed with this assay, in human serum or plasma, are used as aid in diagnosis, monitoring, prognosis, and management of suspected inflammatory disorders and associated diseases, acute infections and tissue injury. Highly sensitive measurement of CRP may also be used as an aid in the assessment of the risk of future coronary heart disease. When used as an adjunct to other laboratory evaluation methods of acute coronary syndromes, it may also be an additional independent indicator of recurrent event prognosis in patients with stable coronary disease or acute coronary syndrome. en